Modern Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Buy
14,380
+3,788
+36% +$499K 0.02% 404
2026
Q1
$1.49M Buy
10,592
+1,170
+12% +$164K 0.03% 345
2025
Q4
$1.16M Buy
9,422
+1,247
+15% +$152K 0.02% 378
2025
Q3
$907K Buy
8,175
+97
+1% +$11K 0.02% 409
2025
Q2
$896K Buy
8,078
+1,179
+17% +$125K 0.02% 381
2025
Q1
$773K Buy
6,899
+1,351
+24% +$139K 0.02% 342
2024
Q4
$513K Buy
5,548
+2,491
+81% +$224K 0.02% 361
2024
Q3
$256K Buy
+3,057
New +$233K 0.02% 372

Other funds holding GILD

Modern Wealth Management's GILD Position: Q2 2026 in Review

Modern Wealth Management increased its Gilead Sciences (GILD) stake by 36% in Q2 2026, buying an estimated $499K and bringing the position to 14,380 shares worth $1.82M. The position accounts for 0.02% of the portfolio, ranked #404.

Modern Wealth Management first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Modern Wealth Management held 14,380 shares of Gilead Sciences worth $1.82M as of Q2 2026.
  • Modern Wealth Management bought 3,788 Gilead Sciences shares in Q2 2026, an estimated $499K.
  • Gilead Sciences made up 0.02% of Modern Wealth Management's portfolio in Q2 2026, its #404 holding.
  • Modern Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.